The news about Gilead's remdesivir therapeutic treatment for COVID-19 keeps getting better. The current findings, reported this week, provide rigorous demonstration of potent inhibition of SARS-CoV-2

Do you think the price is fair?

$GILD #nasdaq #stocks https://t.co/s9QnvK90Kg